| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.2 | 0.5 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |